| pubmed-article:16282839 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16282839 | lifeskim:mentions | umls-concept:C0456909 | lld:lifeskim |
| pubmed-article:16282839 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:16282839 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:16282839 | lifeskim:mentions | umls-concept:C0073393 | lld:lifeskim |
| pubmed-article:16282839 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:16282839 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16282839 | lifeskim:mentions | umls-concept:C0205266 | lld:lifeskim |
| pubmed-article:16282839 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16282839 | pubmed:dateCreated | 2005-11-11 | lld:pubmed |
| pubmed-article:16282839 | pubmed:abstractText | Controlled clinical trials in pediatric psychopharmacology rely on blinded parents and clinical evaluators for outcome data, but little is known about the success of the masking procedures. The blindness of clinical evaluators and parents was examined in a clinical trial of risperidone in autism. | lld:pubmed |
| pubmed-article:16282839 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282839 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282839 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282839 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282839 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16282839 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282839 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16282839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282839 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16282839 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16282839 | pubmed:issn | 0271-0749 | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:PoseyDavid... | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:McDougleChris... | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:VitielloBened... | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:DaviesMarkM | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:ArnoldL... | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:McCrackenJame... | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:ScahillLawren... | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:KoenigKathlee... | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:TierneyElaine... | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:AmanMichaelM | lld:pubmed |
| pubmed-article:16282839 | pubmed:author | pubmed-author:SwiezyNaomi... | lld:pubmed |
| pubmed-article:16282839 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16282839 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:16282839 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16282839 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16282839 | pubmed:pagination | 565-9 | lld:pubmed |
| pubmed-article:16282839 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:meshHeading | pubmed-meshheading:16282839... | lld:pubmed |
| pubmed-article:16282839 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16282839 | pubmed:articleTitle | Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone. | lld:pubmed |
| pubmed-article:16282839 | pubmed:affiliation | Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, MD 20892-9633, USA. bvitiell@mail.nih.gov | lld:pubmed |
| pubmed-article:16282839 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16282839 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| pubmed-article:16282839 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16282839 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
